These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 21969238

  • 21. [Clinical features of familial multiple sclerosis in Spain].
    Fernández-Pérez MJ, Barakat O, García-Moreno JM, Lucas M, Navarro G, Gata JM, Gamero MA, Duque P, Izquierdo G.
    Rev Neurol; ; 29(8):693-6. PubMed ID: 10560101
    [Abstract] [Full Text] [Related]

  • 22. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Jiménez-Jiménez FJ, Hernánz A, Medina-Acebrón S, de Bustos F, Zurdo JM, Alonso H, Puertas I, Barcenilla B, Sayed Y, Cabrera-Valdivia F.
    Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
    [Abstract] [Full Text] [Related]

  • 23. Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
    Albanese M, Zagaglia S, Landi D, Boffa L, Nicoletti CG, Marciani MG, Mandolesi G, Marfia GA, Buttari F, Mori F, Centonze D.
    J Neuroinflammation; 2016 Feb 10; 13():36. PubMed ID: 26863878
    [Abstract] [Full Text] [Related]

  • 24. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S.
    J Med Assoc Thai; 2011 Feb 10; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [Abstract] [Full Text] [Related]

  • 25. Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
    Gajofatto A, Bongianni M, Zanusso G, Bianchi MR, Turatti M, Benedetti MD, Monaco S.
    Acta Neurol Scand; 2013 Nov 10; 128(5):336-44. PubMed ID: 23550839
    [Abstract] [Full Text] [Related]

  • 26. [Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors].
    Flachenecker P, Hartung HP.
    Nervenarzt; 1996 Jun 10; 67(6):444-51. PubMed ID: 8767198
    [Abstract] [Full Text] [Related]

  • 27. Neurofilaments as biomarkers in multiple sclerosis.
    Teunissen CE, Khalil M.
    Mult Scler; 2012 May 10; 18(5):552-6. PubMed ID: 22492131
    [Abstract] [Full Text] [Related]

  • 28. Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis.
    Guimarães I, Cardoso MI, Sá MJ.
    Mult Scler; 2006 Jun 10; 12(3):354-6. PubMed ID: 16764350
    [Abstract] [Full Text] [Related]

  • 29. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C, Bensa C, Debouverie M, Wiertlevski S, Brassat D, de Seze J, Rumbach L, Pelletier J, Labauge P, Brochet B, Tourbah A, Clavelou P, Club Francophone de la Sclérose en Plaques.
    Arch Neurol; 2009 Jul 10; 66(7):841-6. PubMed ID: 19597085
    [Abstract] [Full Text] [Related]

  • 30. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
    Markianos M, Koutsis G, Evangelopoulos ME, Mandellos D, Karahalios G, Sfagos C.
    J Neurochem; 2009 Jan 10; 108(1):158-64. PubMed ID: 19014375
    [Abstract] [Full Text] [Related]

  • 31. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
    Knudsen S, Jennum PJ, Korsholm K, Sheikh SP, Gammeltoft S, Frederiksen JL.
    Mult Scler; 2008 Jul 10; 14(6):734-8. PubMed ID: 18505777
    [Abstract] [Full Text] [Related]

  • 32. CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
    Kester MI, van der Vlies AE, Blankenstein MA, Pijnenburg YA, van Elk EJ, Scheltens P, van der Flier WM.
    Neurology; 2009 Oct 27; 73(17):1353-8. PubMed ID: 19858456
    [Abstract] [Full Text] [Related]

  • 33. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, Bertolotto A, Martinelli V, Comi G, Filippi M.
    Mult Scler; 2009 Jul 27; 15(7):789-94. PubMed ID: 19465450
    [Abstract] [Full Text] [Related]

  • 34. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
    Teunissen CE, Dijkstra C, Polman C.
    Lancet Neurol; 2005 Jan 27; 4(1):32-41. PubMed ID: 15620855
    [Abstract] [Full Text] [Related]

  • 35. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
    Hampel H, Teipel SJ, Fuchsberger T, Andreasen N, Wiltfang J, Otto M, Shen Y, Dodel R, Du Y, Farlow M, Möller HJ, Blennow K, Buerger K.
    Mol Psychiatry; 2004 Jul 27; 9(7):705-10. PubMed ID: 14699432
    [Abstract] [Full Text] [Related]

  • 36. Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
    Hedegaard CJ, Sellebjerg F, Krakauer M, Hesse D, Bendtzen K, Nielsen CH.
    Mult Scler; 2011 May 27; 17(5):567-77. PubMed ID: 21177756
    [Abstract] [Full Text] [Related]

  • 37. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
    Jiang Y, Yang Y, Zhang B, Peng F, Bao J, Hu X.
    Neuro Endocrinol Lett; 2009 Mar 27; 30(1):85-90. PubMed ID: 19300400
    [Abstract] [Full Text] [Related]

  • 38. Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
    Møllgaard M, Degn M, Sellebjerg F, Frederiksen JL, Modvig S.
    Eur J Neurol; 2016 May 27; 23(5):898-905. PubMed ID: 26872061
    [Abstract] [Full Text] [Related]

  • 39. Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients.
    Garcia-Martin E, Pueyo V, Ara JR, Almarcegui C, Martin J, Pablo L, Dolz I, Sancho E, Fernandez FJ.
    Mult Scler; 2011 Jul 27; 17(7):830-7. PubMed ID: 21300734
    [Abstract] [Full Text] [Related]

  • 40. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury.
    Ost M, Nylén K, Csajbok L, Ohrfelt AO, Tullberg M, Wikkelsö C, Nellgård P, Rosengren L, Blennow K, Nellgård B.
    Neurology; 2006 Nov 14; 67(9):1600-4. PubMed ID: 17101890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.